Towa

Avalara Announces 17 Newly Certified Integrations into Business Applications

Retrieved on: 
Wednesday, November 1, 2023
Cloud, Sale, Catalog, Arcadis, Auction software, Tax, Supply chain, AFC, Telephone, Microsoft, B2B, Software, Internet, Risk, Marketing, Microsoft Dynamics 365, MACC, API, Towa, Workflow, CRM, Accounting, ERP, POS, Online shopping, Internet service provider, Warehouse, Sales

Avalara certified integration partners have met criteria developed by Avalara for performance and reliability.

Key Points: 
  • Avalara certified integration partners have met criteria developed by Avalara for performance and reliability.
  • Additionally, these integrations enable customers of Avalara partner solutions to benefit from Avalara's real-time calculation of applicable taxes for billing line items.
  • For more information about the Avalara certified integration program, and a list of all our certified integrations, please visit avalara.com/integrations .
  • For any business application not already certified, or for a custom solution, Avalara offers an API for each of its products, making customer integrations simple for nearly any developer or business to build.

Breckenridge Signs New-Product Agreement with PTS Pharma

Retrieved on: 
Friday, April 22, 2022
NDA, CEO, Towa, Clinical trial, LLC, Tablet, PTS, Ownership, Negotiation, Suppository, Capsule, GMP, Patient, Suspension, Technology, Multimedia, Industry, Quality of life, Anda, Towa Pharmaceutical Ractab Dome, Health, Fine chemical

BERLIN, Conn., April 22, 2022 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announces today that it has signed a new-product agreement with PTS Pharma, LLC.

Key Points: 
  • BERLIN, Conn., April 22, 2022 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announces today that it has signed a new-product agreement with PTS Pharma, LLC.
  • of a complex "For Suspension" product developed by PTS.
  • PTS Consulting, LLC and PTS Pharma LLC., is a formulation development, clinical trial production, regulatory services and analytical control laboratory based in Kansas.
  • PTS Pharma is also involved in active raw material clinical production by fermentation technology processes.

Luye Pharma enters into an agreement with ESTEVE to commercialize an Alzheimer's Disease Multi-Day Treatment Patch in Spain

Retrieved on: 
Thursday, September 16, 2021
Friends, European Union, Knowledge, R, Quality of life, Central nervous system, Center, Dementia, Marketing, Alzheimer's disease, Microparticle, Caregiver, Metabolism, Towa, Patient, Union, Liposome, GMP, III, General manager, National Medical Products Administration, Solution, Tablet, Review, Brain, CNS, Memory, Central, Sale, Cholinesterase, Thought, Fine chemical, Pharmaceutical industry

BASEL, Switzerland, Sept. 16, 2021 /PRNewswire/ --Luye Pharma Switzerland AG ("Luye Switzerland"), a fully owned subsidiary of Luye Pharma Group (Luye Pharma), and Esteve Pharmaceuticals, S.A. (ESTEVE) announced today that they have entered into an agreement under which ESTEVE receives exclusive rights to commercialize the Rivastigmine Multi-Day Transdermal Patch in Spain.

Key Points: 
  • BASEL, Switzerland, Sept. 16, 2021 /PRNewswire/ --Luye Pharma Switzerland AG ("Luye Switzerland"), a fully owned subsidiary of Luye Pharma Group (Luye Pharma), and Esteve Pharmaceuticals, S.A. (ESTEVE) announced today that they have entered into an agreement under which ESTEVE receives exclusive rights to commercialize the Rivastigmine Multi-Day Transdermal Patch in Spain.
  • Xavier Valera, Managing Director Spain at ESTEVE commented: "This agreement allows ESTEVE to bring this innovative treatment to Spain and to complement our neurology-based portfolio in order to improve the quality oflife of our patients."
  • "The collaboration with ESTEVE represents an important milestone in our commitment to addressing unmet needs for senior patients in Europe.
  • Luye Pharma Group (Luye Pharma), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing, and sale of innovative medications.

Bright Computing Announces Partnership with Japanese Firm Towa Electric

Retrieved on: 
Friday, September 7, 2018
Computing, Cluster computing, Cloud infrastructure, Bright Computing, Cloud computing, Data management, Supercomputers, Information and communications technology, Towa

Towa Electric has chosen to partner with Bright Computing for two reasons: Firstly, to harness the power of Bright Cluster Manager to offer ease-of-use and ease-of-management to its end users, and secondly to bring ease-of-system-integration to both Towa and GDEP.

Key Points: 
  • Towa Electric has chosen to partner with Bright Computing for two reasons: Firstly, to harness the power of Bright Cluster Manager to offer ease-of-use and ease-of-management to its end users, and secondly to bring ease-of-system-integration to both Towa and GDEP.
  • Tadamichi Iino, CEO at Towa Electric and GDEP Advance, commented; "Towa Electric Inc. is a HPC Datacenter Strategic Partner of Intel Corporation.
  • Clemens Engler, Director Business Development at Bright Computing, added; "Towa Electric offers compelling solutions for the HPC and deep learning markets in Japan, and we are delighted that they have signed a partnership agreement with us, to install Bright technology into customer data centers across the region.
  • For more information about Bright Computing and Towa Electric, please email [email protected].